Bibliography

Filters: First Letter Of Keyword is A  [Clear All Filters]
1987
Tedford CE, Schott MJ, Flynn JR, Cannon JG, Long JP. A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Tedford CE, Schott MJ, Flynn JR, Cannon JG, Long JP. A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
1989
Gross PF. Technology assessment in health care in Australia. Int J Technol Assess Health Care. 1989;5(1):137-53.
1991
Roseman CB, Patrick WK, Tucker RV. Health technology assessment: a policy-relevant technology diffusion model for emerging economies of the Asia and Pacific region. Asia Pac J Public Health. 1991;5(1):10-4.
Hailey DM, Crowe BL. Health technology assessment: an Australian perspective. Med Prog Technol. 1991;17(2):103-9. Abstract
Danneskiold-Samsøe B. Technology assessment activities in Denmark. Int J Technol Assess Health Care. 1991;7(1):76-83.
1994
Smith CS, Hailey D, Drummond M. The role of economic appraisal in health technology assessment: the Australian case. Soc Sci Med. 1994;38(12):1653-62. Abstract
Smith CS, Hailey D, Drummond M. The role of economic appraisal in health technology assessment: the Australian case. Soc Sci Med. 1994;38(12):1653-62. Abstract
1996
Hailey DM. Health technology assessment in Australia: a need to re-focus. J Qual Clin Pract. 1996;16(3):123-9. Abstract
1997
Kearney B, Willis E. Health technology assessment in Australia: the role of AHTAC. Australian Health Technology Advisory Committee. Australas Phys Eng Sci Med. 1997;20(4):193-7. Abstract
van den Heuvel WJ, Wieringh R, van den Heuvel LP. Utilisation of medical technology assessment in health policy. Health Policy. 1997;42(3):211-22. Abstract
van den Heuvel WJ, Wieringh R, van den Heuvel LP. Utilisation of medical technology assessment in health policy. Health Policy. 1997;42(3):211-22. Abstract
Fernandez AM, Schrogie JJ, Wilson WW, Nash DB. Technology assessment in healthcare: a review and description of a "best practice" technology assessment process. Best Pract Benchmarking Healthc. 1997;2(6):240-53. Abstract
1999
Weedon D. Health technology assessment in Australia. Med J Aust. 1999;171(10):551-2.
2000
Lehoux P, Blume S. Technology assessment and the sociopolitics of health technologies. J Health Polit Policy Law. 2000;25(6):1083-120. Abstract
Wild C. Health technology assessment in Austria. Int J Technol Assess Health Care. 2000;16(2):303-24. Abstract
Jørgensen T, Hvenegaard A, Kristensen FB. Health technology assessment in Denmark. Int J Technol Assess Health Care. 2000;16(2):347-81. Abstract
Jørgensen T, Hvenegaard A, Kristensen FB. Health technology assessment in Denmark. Int J Technol Assess Health Care. 2000;16(2):347-81. Abstract
Jørgensen T, Hvenegaard A, Kristensen FB. Health technology assessment in Denmark. Int J Technol Assess Health Care. 2000;16(2):347-81. Abstract
Lauslahti K, Roine R, Semberg V, Kekomäki M, Konttinen M, Karp P. Health technology assessment in Finland. Int J Technol Assess Health Care. 2000;16(2):382-99. Abstract
Perleth M, Busse R. Health technology assessment in Germany. Status, challenges, and development. Int J Technol Assess Health Care. 2000;16(2):412-28. Abstract
Granados A, Sampietro-Colom L, Asua J, Conde J, Vazquez-Albertino R. Health technology assessment in Spain. Int J Technol Assess Health Care. 2000;16(2):532-59. Abstract
2001
Braunack-Mayer A. Casuistry as bioethical method: an empirical perspective. Soc Sci Med. 2001;53(1):71-81. Abstract
Derry S, Loke YK, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol. 2001;1:7. Abstract
Derry S, Loke YK, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol. 2001;1:7. Abstract